The small fact that it was not possible at that time to accurately
assess the overall dynamics of these interactions in vivo.
We found that founder transgenic embryos expressing high levels of MafK died of severe anemia. In conIn particular, the significance of possible antagonistic (positive or negative) regulation by the small Maf factors trast, mice producing lower amounts of MafK or MafG completed gestation, thus allowing us to establish small alone had not been established. We therefore set out to examine the physiological consequences of modulating Maf-expressing transgenic lines. While erythropoiesis was normal in these (gain-of-function) lines, their megasmall Maf concentrations in vivo to test for hypothetical bidirectional control by these proteins within the context karyocytes displayed reduced proplatelet formation (PPF) and reduced megakaryocytic MARE-dependent of the entire repertoire of other bZip transcription factors (e.g., small and large Mafs, CNC proteins, and Jun/Fos gene expression, phenotypes remarkably similar to those observed in mafG germ line mutant mice. When family members) that might be present in a normal cellular milieu.
we intercrossed the mafG null mutants with the GATA-1-directed MafK or MafG transgenics, we found that the In order to examine the effect of small Maf overexpression on a single MARE-dependent process, we genermegakaryocytic phenotype was rescued in compound mutants. These experiments directly demonstrate that ated transgenic mice bearing either a MafK or MafG cDNA directed by a GATA-1 gene regulatory cassette, the MARE constitutes a sensitive genetic switch that mediates repression or activation as a consequence of since the MARE is known to act as a critical cis element for gene regulation in both erythroid and megakaryothe quantitative balance between small Maf transcription factors and their partners. cytic cells. We previously showed that three separate segments of the GATA-1 gene (including an erythroid promoter, a 5Ј distal element, and an element in the Results first intron) together comprise the sequences that are necessary and sufficient for exerting full GATA-1 tran-
Myeloid-Specific MafK Overexpression in Founders Causes Lethal Embryonic Anemia scriptional control in erythroid as well as megakaryocytic lineages (Onodera et al., 1997). We thus hoped to
To analyze the effects of modulating MafK abundance on megakaryopoiesis and erythropoiesis, we generated determine the effects of small Maf gain-of-function in vivo after restricting its expression to a specific subset transgenic mice bearing a MafK cDNA placed under the control of the GATA-1 locus hematopoietic regulatory of well characterized myeloerythroid lineage cells. domain (G1-HRD) that restricts transgene expression to entiation process per se was less severely affected by erythroid cells and megakaryocytes (Experimental Proan excess of transgene-derived MafK. As expected from cedures; Onodera et al. 1997 ). Since the G1-HRD is the decrease in blood cell number, the mRNA level first activated in hematopoietic cells of the yolk sac, we of MARE-dependent erythroid genes (e.g., ⑀y-globin, examined primitive erythropoiesis in founder transgenic ALAS-E, and PBGD) was diminished in whole yolk sacs embryos (F 0 assay).
of the transgenic embryos (data not shown).
Transgenic founders recovered at gestational days
Since some transgenic embryos did not appear to be 10.5 and 11.5 (E10.5 and E11.5) were examined macroanemic, we speculated that the expression level of the scopically for anemia. We found that four of twentyMafK transgene among individual embryos might be six (15.4%) E10.5 and three out of eight (37.5%) E11. 5) . These results, however, must red blood cells prior to E10.5 (Onodera et al., 1997). The be interpreted in light of the conspicuous diminution in observed embryonic anemia was the first detectable blood cell number in the severely anemic embryos (see direct effect of MafK overexpression, subsequently Figures 1C and 1D ). When normalized to erythroid cellleading to secondary growth retardation and embryonic specific GATA-1 mRNA, the data indicate that total MafK demise.
(both endogenous and transgene-derived) mRNA was We next performed histological analysis of the transexpressed approximately 16-to 24-fold more abungenic embryos. Three F 0 embryos at E10.5 were secdantly in the blood of transgenic embryos with protioned and stained with hematoxyline and eosin, and 10 nounced anemia ( Figure 1G , lanes 1 and 2) or 1.6-fold separate sections were examined in detail. As expected, higher in those displaying no anemia (lane 3). Thus, the the number of circulating blood cells was significantly level of transgene-derived MafK mRNA correlates fewer in the heart cavity and major vasculature of transstrongly with the severity of anemia. This result suggests genic embryos ( Figures 1C and 1D ). Despite the scarcity that robust expression of the MafK transgene leads to of red blood cells, they were hemoglobinized in the aneembryonic lethality by disrupting primitive erythropoiemic transgenic embryos ( Figures 1E and 1F ). This obsersis, while modestly elevated levels of MafK do not intervation suggested that the proliferation of erythroid progenitors might be compromised, but that the differfere with embryogenesis. We next generated transgenic mice bearing the MafK and the adverse effect of MafK overexpression on primitive erythropoiesis is due, at least in part, to its ability L2PM4P mutant cDNA driven by the G1-HRD, and compared the phenotype of these transgenic animals to to dimerize and/or to bind DNA. Therefore, we conclude that excess transgene-derived MafK acts directly on those generated using wild-type MafK cDNA. To quantify the comparison, we established criteria for evaluat-MARE sites in vivo to negatively regulate primitive erythropoiesis. ing anemic severity where the number of red blood cells in the yolk sac vasculature, embryonic heart cavity, and aortic cavity were independently assigned numerical Surplus Small Maf Inhibits Proplatelet Formation in Megakaryocytes values from 0 to 2. The mean hematopoietic score is then the sum of the three independent scores (Table  While excessive MafK expression in embryos led to anemic death, some transgenic embryos were able to es-1A). F 0 embryos were first scored macroscopically and then genotyped by PCR (Table 1B) . When transgenic cape lethality, presumably because the transgene was expressed at sublethal dosages. We were therefore able embryos injected with wild-type MafK cDNA were examined, scores of less than 3 (i.e., relatively severe anemia) to establish transgenic lines to examine the effect of (in most cases, slight) MafK overexpression on definitive were recorded for 2/6 (E9.5), 11/46 (E10.5), or 4/11 karyocytes, the major MARE binding activity was p45/ ties (if any) in an in vivo situation that was sensitive to variations in small Maf concentration, and thus perhaps small Maf heterodimers, which react with an anti-small Maf antiserum (that recognizes both MafK and MafG) as in the regulation of PPF. To this end, four independent MafG-overexpressing transgenic lines were generated well as with anti-p45 ( Figure 3F, lanes 1-4) . In contrast, megakaryocytes recovered from MafK transgenics disby coinjecting G1-HRD-MafG and G1-HRD-GFP into fertilized eggs. The expression levels in each line were played an intense binding activity which was ablated by inclusion of the anti-small Maf antibody, but was examined by immunoblotting with the anti-small Maf antiserum ( Figure 3G ). Tg MafG825 was the highest MafG unaffected by addition of anti-p45 ( Figure 3F, lanes 5-8) . Thus, the higher mobility complex did not contain p45, producer, while others (lines 705, 708, and 675) were low producers. When PPF in these independent lines as the intensity of the supershifted band remained constant upon addition of excess anti-p45 ( Figure 3F , lanes was examined, Tg MafG825 displayed prominent inhibition, while line Tg
MafG705
, a low producer, showed none (Table  11 and 12) . Furthermore, the high mobility protein:DNA complex comigrated with in vitro translated MafK (Fig-2A) Figure 4A ). When we measured PPF in megakaryocytes recovered from mafG Ϫ/Ϫ :: Tg MafK/GFP or Tg MafG/GFP compound mutant mice, the frequency was close to normal ( Figure 4D ; Table 2B ). In contrast, no PPF recovery was observed in control compound mutant mafG Ϫ/Ϫ ::Tg GFP megakaryocytes ( Figure  4E ). Among the MafK transgenics, PPF recovery was more efficient in lines 548 and 686, which produce MafK at relatively higher levels (Table 2B) , while, conversely, only 50% PPF recovery was seen when line 549 (a low level MafK producer; Table 2B ) was employed. Among the MafG transgenics, line 825, which produces MafG at high levels, displayed the most efficient PPF restoration in the mafG null mutant background (Table 2B) , while line 705, which expressed MafG at very low levels, displayed inefficient PPF recovery (Table 2B) . These results If erythroid progenitors begin to differentiate when the The only exception to this conclusion was provided from MafK transgene is transcribed, then this may cue precostudies of the mafK::mafG compound mutant mouse, cious erythroid differentiation and thus indirectly prowhich displayed erythroid membrane abnormalities hibit adequate proliferation and expansion of the pro- (Onodera et al., 2000) . However, erythropoiesis in this genitor pool. compound mutant was deemed normal as judged by Unlike its effect on erythropoiesis, megakaryopoiesis the production of globins and heme biosynthetic enwas affected by even low MafK transgene levels, rezymes and the presence of enucleated definitive red sulting in striking PPF inhibition. This suggests that at blood cells. These observations raised the question of least one stage of megakaryopoiesis is much more senwhether or not MARE-dependent transcription was acsitive to alterations in small Maf protein concentration tually indispensable for erythropoiesis. than any step in erythropoiesis. Consistent with this notion, only a megakaryocytic phenotype was observed The analysis of MafK transgenic overexpression mice Figure 4A indicate that the high producer MafK lines (e.g., Tg MafK686 ) are expressed at 2-fold higher levels than the high producer mesoderm formation in mouse development. Genes Dev. 11, 786-798. MafG line (Tg MafG825 ) (1.6-fold), after normalization, the two are calcu-
(E). Acetylcholinesterase activity stains dark brown (B and C), and GFP-positive megakaryocytes were observed by fluorescence microscopy (D and E). (F) Thromboxane synthetase (TXS) mRNA levels were determined transgenic lines (548 and 549) (middle). TXS mRNA levels are fully by real-time quantitative RT-PCR (Experimental Procedures

